Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy
Authors:
- 5 March 2018
- journal article
- editorial
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 15 (9) , 805-807
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Metabolic Regulation of Tregs in Cancer: Opportunities for ImmunotherapyTrends in Cancer, 2017
- Gene expression profiling of CD8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8+ Treg cell productionCell Proliferation, 2016
- TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironmentOncotarget, 2016
- Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairmentCellular & Molecular Immunology, 2015
- Changes of CD4+CD25+FOXP3+ and CD8+CD28− regulatory T cells in non-small cell lung cancer patients undergoing surgeryInternational Immunopharmacology, 2014
- CD11chighCD8+ Regulatory T Cell Feedback Inhibits CD4 T Cell Immune Response via Fas Ligand–Fas PathwayThe Journal of Immunology, 2013
- Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signalJournal of Surgical Oncology, 2012
- Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissueGut, 2008
- CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate CancerClinical Cancer Research, 2007
- Transforming Growth Factor‐Beta1 Gene Transfer is Associated with the Development of Regulatory CellsAmerican Journal of Transplantation, 2005